-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_disposition-comments.pdf
August 01, 2012 - the larger
CKD stages 1-3 group.
6. … 1-3 (or
approximating these stages). … the larger CKD stages
1-3 group. … CKD stages
1-3 group. … CKD stages
1-3 group.
2.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/anal-cancer-key-questions.pdf
January 01, 2018 - KQs)
KQ1: What is the comparative effectiveness of different modalities of initial treatment for stages … What is the comparative effectiveness of different radiation therapy types for initial
treatment of stages … KQ5: What is the effectiveness of immunotherapy for initial treatment of stages I-III squamous
cell … Adults with stages I-III squamous cell anal
cancer
Interventions a. Chemoradiation
b. … Effectiveness of immunotherapy for initial treatment of stages I-III anal carcinoma
a.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/anal-cancer-draft-report.pdf
October 31, 2023 - Treatment of Stages I-III Squamous Cell Anal Cancer: A Systematic Review
i
Draft Comparative Effectiveness … Review
Number xx
Treatment of Stages I-III Squamous Cell Anal Cancer:
A Systematic Review
Prepared … Suggested
language for acknowledgment: This work was based on an evidence report, Treatment of Stages … viii
Treatment of Stages I-III Squamous Cell Anal Cancer:
A Systematic Review
Structured Abstract … What are the effectiveness and harms of immunotherapy for initial treatment of stages I-
III squamous
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_executive.pdf
January 01, 2012 - 1
Comparative Effectiveness Review
Number 37
Chronic Kidney Disease Stages 1–3: Screening,
Monitoring … damage; and (3)
treating adults with CKD stages 1–3. … Treatment of CKD Stages 1–3
In most patients with nonprimary CKD stages 1–3,
treatment is not directed … - Most patients with CKD stages 1–3 are clinically
unrecognized. … Chronic Kidney
Disease Stages 1–3: Screening, Monitoring, and Treatment.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-273-anal-cancer-executive-summary.pdf
August 01, 2024 - Executive Summary_Comparative Effectiveness Review No. 273_Treatment of Stages I-III Squamous Cell Anal … Cancer: A Systematic Review
Comparative Effectiveness Review
Number 273
Treatment of Stages … A Systematic Review
Executive Summary
Main Points
• For the initial treatment of stages … Background and Purpose
CRT with 5FU plus MMC has remained the standard treatment for stages … Treatment of Stages I–III
Squamous Cell Anal Cancer: A Systematic Review.
-
effectivehealthcare.ahrq.gov/decision-aids/prostate-cancer/07.html
June 08, 2018 - Low Risk
Low-risk cancer has PSA levels less than 10 ng/ml, Gleason Scores of 6 or lower, and stages … Intermediate/Medium Risk
Medium-risk cancer has PSA levels of 10–20 ng/ml, Gleason Scores of 7, or stages … High Risk
High-risk cancer has PSA levels of more than 20 ng/ml, Gleason Scores of 8 or higher, or stages
-
effectivehealthcare.ahrq.gov/products/kidney-disease-medicine/research-protocol
July 28, 2010 - Comments Report Jul. 3, 2013 Surveillance Report Screening for and Management of Chronic Kidney Disease Stages … Within this framework, K/DOQI then classified CKD into five stages as follows:
Stage 1: Kidney damage … (2) Albuminuria stages should be added within each GFR stage (urinary ACR <30 mg/g, 30-299 mg/g, or … Population(s):
Adults (≥ 18 years) with CKD stages 1-3. … Population(s):
Adults (≥18 years) with CKD stages 1-3.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-staging_executive.pdf
September 01, 2014 - How good is endoscopic
ultrasound in differentiating various T stages of rectal cancer?
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_surveillance.pdf
October 01, 2012 - CER # 37:
Chronic Kidney Disease Stages 1–3: Screening, Monitoring, and
Treatment
Original release … ESRD was not
significantly reduced in patients
with CKD stages 1–3 who did
not have proteinuria. … ESRD was not significantly reduced in
patients with CKD stages 1–3 who did not
have proteinuria. … Chronic Kidney Disease Stages 1-3:
Screening, Monitoring, and Treatement. … New Evidence:
Most patients with CKD stages 1–3 are
clinically unrecognized.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/kidney-disease-medicine_research-protocol.pdf
November 01, 2010 - Systematic Review Protocol
Project Title: Screening for and Management of Chronic Kidney
Disease Stages … Chronic Kidney Disease (CKD)
There has been substantial debate regarding how best to define early stages … (2) Albuminuria stages should be added within each GFR stage (urinary ACR <30 mg/g,
30-299 mg/g … • Population(s):
- Adults (> 18 years) with CKD stages 1-3. … • Population(s):
- Adults (> 18 years) with CKD stages 1-3.
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/mild-renal-impairment
May 03, 2008 - Mild renal impairment
Chronic Kidney Disease Stages 1–3: Screening, Monitoring, and Treatment
-
effectivehealthcare.ahrq.gov/products/kidney-disease-medicine/
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/anal-cancer-protocol.pdf
September 26, 2023 - alone, immunotherapy, proton beam
radiotherapy, and de-escalation of radiation dosing for appropriate stages … What are the effectiveness and harms of different modalities of initial treatment
for stages I-III squamous … the effectiveness and harms of different modalities of radiation therapy
for initial treatment of stages … What are the effectiveness and harms of immunotherapy for initial treatment of
stages I-III squamous … adenocarcinomas,
undifferentiated cancer)
5
Studies including mixed populations
with Stages
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ehc-presentation-risk-of-bias.pdf
December 01, 2017 - learner will be able to:
• Describe the importance of determining the risk
of bias
• Identify the stages … And finally, identify the stages of risk of bias assessment. … Stages in Assessing Risk of Bias
1. Develop Protocol
2. Pilot test and train
3. … Report Risk of Bias Findings, Process and
Limitations
Presenter
Presentation Notes
Stages in Assessing … Risk of Bias
There are five stages in assessing risk of bias.
-
effectivehealthcare.ahrq.gov/products/wiki-collaboration/research
September 30, 2011 - In addition to serving as a mechanism for reviewing draft reports, wikis could be used in earlier stages
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-rev-team-confidentiality-form.pdf
September 01, 2018 - independence,
the EPC program has designated specific opportunities for public comment at various stages … its independence, the EPC program has designated specific opportunities for public comment at various stages
-
effectivehealthcare.ahrq.gov/sites/default/files/assessing-quality-quiz.ppt
September 02, 2013 - Quality assessment requires transparency at all stages.
Correct. … Quality assessment requires transparency at all stages.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/fiber-intake-protocol.pdf
August 15, 2023 - Key Question 1a: How does the association vary among people in different life
stages?
III. … Subgroups of
interest
• Specific life stages
o Infants
o Children and adolescents
o Adults (19- … the purpose of DRIs, the Population of interest is the general population (of all
ages, in all life stages … publication data, study design features, population
characteristics (particularly related to life stages … describe the characteristics of the
study participants (particularly including those related to life stages
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/colon-cancer-gene-profiling_technical-brief.pdf
December 01, 2012 - The GEP assay was then applied to samples from patients with
stages B and C (stages II and III) colorectal … One example of publications combining multiple stages of cancer is a
study on the five-gene prognostic … Given the clinical differences between patients with various stages of colon
cancer and between colon … Gene expression profiles in stages II and
III colon cancers: application of a 128-gene
signature. … Predictor c: A tissue-based IVD predicting
progression of disease in colorectal cancer
UICC stages
-
effectivehealthcare.ahrq.gov/products/colon-cancer-gene-profiling/research-protocol
March 13, 2012 - structures). 3 The relative 5-year survival rate for stage II T4a tumors is higher than for T4b lesions. 4 Stages … commented that additional validation studies were needed. 6 GEP tests were noted to be in various stages … Since this report is on patients with stage II colon cancer, publications on the use of GEP for other stages